KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Assets Average (2016 - 2025)

Historic Assets Average for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $80.9 billion.

  • Gsk's Assets Average rose 880.0% to $80.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 billion, marking a year-over-year increase of 880.0%. This contributed to the annual value of $74.7 billion for FY2024, which is 106.4% up from last year.
  • Gsk's Assets Average amounted to $80.9 billion in Q3 2025, which was up 880.0% from $77.8 billion recorded in Q2 2025.
  • In the past 5 years, Gsk's Assets Average ranged from a high of $108.1 billion in Q3 2021 and a low of $70.8 billion during Q4 2022
  • Over the past 5 years, Gsk's median Assets Average value was $76.4 billion (recorded in 2025), while the average stood at $83.7 billion.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 3416.02% in 2022, then surged by 880.0% in 2025.
  • Quarter analysis of 5 years shows Gsk's Assets Average stood at $107.6 billion in 2021, then tumbled by 34.16% to $70.8 billion in 2022, then rose by 6.14% to $75.2 billion in 2023, then rose by 0.94% to $75.9 billion in 2024, then grew by 6.63% to $80.9 billion in 2025.
  • Its Assets Average stands at $80.9 billion for Q3 2025, versus $77.8 billion for Q2 2025 and $76.4 billion for Q1 2025.